US 6204261
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors
expired A61KA61K38/00A61P
Quick answer
US patent 6204261 (Inhibitors of interleukin-1.beta. Converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04